Quantcast

Latest pharmaceutical industry Stories

2014-10-31 20:21:29

CHAPEL HILL, N.C., Oct. 31, 2014 /PRNewswire/ -- The last decade has seen an explosion in the availability of data that can deliver valuable insights for the pharmaceutical sector -- from Electronic Medical Records and clinical trial data to medical claims and patient behavior information. Pharma recognizes the huge potential that Big Data holds for providing critical insights into clinical programs as well as commercial activities, and many organizations are taking steps to develop Big Data...

2014-10-31 16:23:58

MONTREAL, Oct. 31, 2014 /CNW Telbec/ - JSS Medical Research Inc. is pleased to announce that founder and CEO Dr. John S. Sampalis, received the 2014 EY Entrepreneur Of The Year Quebec Health Sciences Award at the regional awards gala in Montreal. "We are proud that John has been honoured for his leadership and innovation through this award," says Dr. Michel Cimon, Member of the Board. "His company's level of dedication to providing quality clinical research services to healthcare...

2014-10-31 12:25:23

AMSTERDAM, October 31, 2014 /PRNewswire/ -- Huge event with 36,000+ global professionals is now the key barometer of future pharma industry health, analysis and forecasting CPhI Worldwide [http://www.cphi.com ], organised by UBM Live, celebrates the closing of its most successful show to date with pre-audit figures estimating more than 36,000+ attendees and 2,500 exhibitors. Held this year in Paris, the show hosted senior-level decision makers...

2014-10-31 08:26:08

SAN DIEGO, Oct. 31, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, today reported financial results for the quarter ended September 30, 2014. Brian M. Culley, the Company's Chief Executive Officer, said: "The third quarter was productive for Mast. Consistent with prior guidance, our 388-patient pivotal Phase 3 study of MST-188 for sickle cell disease is on track to complete enrollment by the end of next year. We now have...

2014-10-31 08:25:29

GAITHERSBURG, Md., Oct. 31, 2014 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc. appointed Quinterol J. Mallette, M.D. as a director of the company. In addition, Dr. Mallette was appointed to the board's audit committee. Dr. Mallette is currently a Senior Analyst at SWK Holdings, Inc., a publically-traded health care-focused specialty finance firm, a position he has held since 2013. From 2011 to 2013, he was the founder and...

2014-10-30 23:10:48

DMG Productions explores the latest breakthroughs in health and medicine. Zug, Switzerland (PRWEB) October 30, 2014 PSI CRO (PSI) announced that they will be featured in an upcoming episode of Innovations with Ed Begley Jr, airing 1Q 2015, via Discovery Channel. Dates and show times TBA. We believe that PSI’s approach and performance addresses the biggest challenge in our industry. According to various sources, more than 90% of trials run behind schedule, costing sponsors millions in...

2014-10-30 23:08:29

DrugDev is sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November. Five investigators and site staff who are members of the DrugDev Network will serve as key thought leaders in interactive and educational panels during the conference. LONDON and AUDUBON, PA (PRWEB) October 30, 2014 DrugDev is proud to be sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6...

2014-10-30 23:04:00

Iraq's National Center for Drug Control and Research becomes part of program that provides resources and training to increase nation's capacity to test for drug quality, as well as screen for counterfeit and substandard medicines. Rockville, MD (PRWEB) October 30, 2014 The National Center for Drug Control and Research (NCDCR) of Iraq is the newest participant in a U.S. Pharmacopeial Convention (USP) program designed to assist developing countries improve medicine quality....

2014-10-30 16:29:19

LEXINGTON, Mass., Oct. 30, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced today third quarter 2014 financial results, and provided other business updates. Sebelipase alfa for LAL Deficiency The company recently started the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for sebelipase alfa as a treatment for patients...

2014-10-30 16:29:12

-- Optimizes resources by leveraging shared-services -- HAYWARD, Calif., Oct. 30, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced a reorganization of its research and development (R&D) organizations and a prioritization of the project portfolios within the generic and brand businesses. As a result of the reorganization, the generic R&D organization will be responsible for early stage product development and analytical functions for all Impax products,...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.